The HCPLive neuropathic pain page is a resource for medical news and expert insights on neuropathy. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for central pain syndrome, and more.
June 23rd 2024
Use of LX9211 showed significant benefits for diabetic peripheral neuropathic pain in the phase 2 RELIEF-DPN 1 trial.
Does Prism Adaptation Hold Promise for Pain Patients?
Pain management research goes far beyond identifying drug development and new uses for existing medication. One particularly interesting but neglected area of study involves prism adaptation, a non-invasive, non-medication procedure that sounds like something straight out of a science fiction novel.
Extended-Release Gabapentin May Hold Promise for Treatment of Fibromyalgia
A number of studies have shown that gabapentin, developed to treat epilepsy, is effective in treating postherpetic neuralgia and painful diabetic neuropathy. Now, a study has revealed that gabapentin may hold promise for treating fibromyalgia as well.
Neck-Specific Exercises Associated with Pain Reduction for Whiplash-Associated Disorders
General physical activity is often part of the prescription for pain patients. But a new secondary analysis published in The European Journal of Pain shows that for patients with whiplash-associated disorders, neck-specific exercises can be effective and well-tolerated as well.
Diabetes: Promising Link Between Low Vitamin D Levels and Painful Neuropathy
June 8th 2015Pain levels due to diabetic peripheral neuropathy (DPN) may be altered depending on patients' vitamin D levels, a British study. The findings will be presented in a poster session on June 8 at the American Diabetes Association 75th Scientific Sessions in Boston, MA.
Ion Pump Offers New Hope for Neuropathic Pain
May 29th 2015Researchers have demonstrate the efficacy of an implantable organic electronic delivery device for the treatment of neuropathic pain in an animal model. The small organic electronic ion pump could be an effective option for patients suffering from severe nerve pain.
Fibromyalgia and Chronic Pain: Which Patients Have It Worse?
May 28th 2015Chronic painful conditions can have a significant negative impact on a patient's quality of life, but are some conditions worse than others? A recent study sought to determine which chronic pain condition creates the biggest burden on patient quality of life.
One Step Closer to Ending Cancer Pain
May 26th 2015University of Toronto researchers have found a novel role for a cell membrane-anchored mediator in cancer pain. They suggest that the serine protease TMPRSS2-a gene previously shown to play a key role in some of the most aggressive forms of androgen-fuelled cancers-appears to be the trigger behind the most severe forms of cancer pain.
‘Pain Gene' Identified Through Those Who Can't Feel Physical Pain
May 26th 2015People with a rare inherited condition known as "congenial insensitivity to pain" (CIP), which makes it impossible for them to feel pain, may hold the answer to providing pain relief for patients suffering with chronic pain.
Strategy for Prescribing Opioids to Patients with Potential Addiction
May 19th 2015Opioid addiction is a serious problem that a subset of patients prescribed opioids for pain could face; however, the issue presents an even more slippery slope for those with chronic pain due to the long-term need for the drugs.
Hepatitis C and Injection Drug Use Top Targets of CDC Prevention Efforts
May 13th 2015In a continuing effort to curb the spread of hepatitis C among the riskiest populations, government health officials recently held a webinar to discuss links between opioid injection drug use and increased cases of the liver disease.
Pharma Changes Alter Opioid Dispensing & Overdose Rates
May 11th 2015Research from Harvard Medical School and Boston University School of Medicine indicates that opioid dispensing and prescription opioid overdoses decreased substantially following two major changes in the pharmaceutical market in 2010: the introduction of abuse-deterrent, extended-release oxycodone hydrochloride and withdrawal of propoxyphene.
Chronic Itch: Gastrointestinal Peptides as Possible Contributors
May 5th 2015Chronic itch (itch last 6 weeks or longer) is a clinical challenge, and is associated with a number of dermatologic, systemic, neuropathic, and psychogenic causes. Transmission of the itch sensation is similar to that of pain, but distinct in several ways. Scientists have found itch-specific neuronal pathways that when activated, cause considerable discomfort for patients. Current available treatments, however, are still more trial-and-error than evidence-based.